Purpose
to develop a standardized analytical commutability protocol that Developing Country Vaccine Manufacturers may use for evaluating Vi-conjugate ELISA assays and reference standards to support product registration
Grantee
Division
Global Health
Date
MARCH 2016
Region served
GLOBAL
Committed amount
$50,025
Grant topic
Enteric and Diarrheal Diseases
Duration (months)
12
Grantee location
Atlanta, Georgia, United States
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.